List of works - Shawn M Jensen

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

scientific article published on 8 December 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

Adoptive cellular immunotherapy of cancer: a three-signal paradigm for translating recent developments into improved treatment strategies.

scientific article

Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effects.

scientific article

Cytomegalovirus containing TRP2 antigen provides protective immunity against the poorly immunogenic B16BL6-D5 melanoma

scientific article published on 7 November 2013

Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity.

scientific article

Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma.

scientific article

Evidence for the genetic control of estradiol-regulated responses. Implications for variation in normal and pathological hormone-dependent phenotypes

scientific article published on June 1997

Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10 ⬇️

scientific article published on 01 May 2020

Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion.

scientific article published on 16 December 2016

Induction of circulating tumor-reactive CD8+ T cells after vaccination of melanoma patients with the gp100 209-2M peptide

scientific article

Manipulating the host response to autologous tumour vaccines.

scientific article

Multiple vaccinations: friend or foe.

scientific article published on September 2011

Multispectral Imaging of T and B Cells in Murine Spleen and Tumor.

scientific article published on 18 March 2016

Partial CD4 depletion reduces regulatory T cells induced by multiple vaccinations and restores therapeutic efficacy.

scientific article

Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma

scientific article published on 7 November 2013

Regression of a mammary adenocarcinoma in STAT6-/- mice is dependent on the presence of STAT6-reactive T cells

scientific article published on February 2003

Signaling through OX40 enhances antitumor immunity

scientific article published on October 2010

Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

scientific article published on 12 August 2013

Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism ⬇️

scientific article published on August 2, 2011

Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells

scientific article

List of works by Shawn M Jensen

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Adoptive cellular immunotherapy of cancer: a three-signal paradigm for translating recent developments into improved treatment strategies.

Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effects.

Cytomegalovirus containing TRP2 antigen provides protective immunity against the poorly immunogenic B16BL6-D5 melanoma

Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity.

Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma.

Evidence for the genetic control of estradiol-regulated responses. Implications for variation in normal and pathological hormone-dependent phenotypes

Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10 ⬇️

Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion.

Induction of circulating tumor-reactive CD8+ T cells after vaccination of melanoma patients with the gp100 209-2M peptide

Manipulating the host response to autologous tumour vaccines.

Multiple vaccinations: friend or foe.

Multispectral Imaging of T and B Cells in Murine Spleen and Tumor.

Partial CD4 depletion reduces regulatory T cells induced by multiple vaccinations and restores therapeutic efficacy.

Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma

Regression of a mammary adenocarcinoma in STAT6-/- mice is dependent on the presence of STAT6-reactive T cells

Signaling through OX40 enhances antitumor immunity

Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism ⬇️

Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells